A leading pharmaceutical company in Amyotrophic Lateral Sclerosis (ALS) is interested in speaking with startups whose technology could contribute to very early diagnosis of the disease.
W.L. Gore & Associates has recently launched a Sustainability Initiative to explore business opportunities that will create a more sustainable future. They are interested in meeting and exploring ideas to work together with startups that have created innovative material technologies that fit the theme of a sustainable future across a broad range of application areas. In particular, they are seeking new material advancements in cleantech (such as membranes), catalysis, separations and biofabrication.
Halliburton Labs is looking for their next cohort. Applications now open by July 26.
P&G is looking for new approaches and technologies that can help them to address key business challenges/opportunities.
The annual MIT Startup Ecosystem Conference features 25 of the most promising startups from across MIT. These startups are all part of STEX25, an accelerator run by MIT Startup Exchange, an integrated program of MIT Corporate Relations. The conference is the MIT Startup Exchange flagship event, and is a must-attend for executives at industry-leading corporations, especially for those who work in innovation, emerging technology, corporate venture capital, and/or corporate development/strategy.
Please join us at our annual Research and Development Conference on November 15-16, 2023, to hear from MIT leadership, researchers, MIT Startup Exchange entrepreneurs, and global business leaders dedicated to building a better future.
Many corporates have expressed interests in more effective supply chain management and greater operational efficiency. Covid-19 has put greater pressure on supply chain. Apply to speak if your startup has an innovative solution for supply chain management.
The 2024 MIT Health Science Technology Conference will highlight broad and transformative trends in biology and healthcare, including early-stage discovery, immune cell responses, diagnostics, clinical capabilities, process development, rapid and continuous manufacturing, robotics and automation, and sustainability, all enhanced by artificial intelligence and machine learning technologies. Leading MIT researchers and MIT-connected startups will showcase these advances and discuss their implications for improving human health.